23 Jul, 2026
According to Straits Research, the global neurovascular devices market size was valued at $3.35 billion in 2025 and is projected to grow from $3.54 billion in 2026 to $5.49 billion by 2034 at a CAGR of 5.64% during the forecast period 2026-2034.
Interventional neurovascular devices treat diseases of the arteries that carry oxygenated blood to the brain. Neurovascular thrombectomy devices are used to remove the clot that caused the stroke in a complicated aneurysm. This class includes several types of endovascular aids, such as snares, vacuums, and clot extraction tools. The growing population of seniors is one of the most important trends influencing the neurovascular devices industry. Several factors are contributing to the growth of the neurovascular devices market. One of these is the quickening rate of technological development in this area.
It's important to note that any problem with the brain's blood supply might have devastating effects. In other words, people with neurovascular diseases must get prompt medical attention. Furthermore, several factors, such as excessive levels of bad cholesterol, high blood pressure, and diabetes, have a part in the development of neurovascular disorders. Hypertension and intracranial stenosis are risk factors for ischemic stroke. In addition, hypertension is a significant risk factor for conditions like ischemic stroke.
Conditions affecting the brain and blood vessels, such as aneurysms, strokes, and abnormalities, are rising at startling rates. This tendency directly contributes to the rising need for neurovascular devices. For instance, the National Center for Chronic Disease Prevention and Health Promotion estimates that every year about 795,000 Americans suffer from a stroke. Increased demand is driving growth in the global market for neurovascular devices. About 8-10% of aneurysms will rupture yearly, a very high incidence. Aneurysms require rapid treatment due to the great danger of rupture. Also, the use of neurovascular devices is essential to the treatment, which fuels the industry's growth.
North America is the most significant shareholder in the global neurovascular devices market. The increased accessibility of neurovascular devices is a contributing factor. Among the most recognizable names in the North American neurovascular device market are Johnson & Johnson, Integer Holdings Corporation, and Penumbra, Inc. Due to the presence of these key companies, neurovascular devices are becoming increasingly accessible in the region, fueling the market's growth. The growing number of retirees in the region is also fueling business growth. Because hypertension, the primary cause of ischemic stroke, is also prevalent in the area, more people are at risk of having an ischemic stroke.
Asia-Pacific is expected to grow during the forecast period. China, Japan, India, Australia, South Korea, and the rest of Asia and the Pacific make up the region. The neurovascular devices market has great potential in Asia and the Pacific. A significant population and a vast patient base for neurovascular illnesses make this the most promising area for growth over the projection period. An aging population in countries like Japan is helping to drive the neurovascular devices market growth in Asia. Due to the high frequency of age-related diseases like hypertension, this population is also at a higher risk of acquiring neurovascular disorders like stroke.
Within the global market for neurovascular devices, Europe held the second largest share. The region is renowned for its innovative medical discoveries and technical breakthroughs, which is why it has attracted so much attention. The increasing senior population in Europe is a key driver propelling the neurovascular devices market in the region. Due to their advanced age, this population group is disproportionately affected by neurovascular diseases such as ischemic stroke and risk factors such as hypertension and diabetes. The rise in the incidence of neurovascular diseases is another factor driving the market expansion.
The market for neurovascular devices in LAMEA is still in its infancy due to the region's limited purchasing power. Several factors hamper the expansion of the market for neurovascular devices in LAMEA. Lack of access, insufficient resources, and gaps in care are some of the issues plaguing the healthcare system today. However, regional governments have increased healthcare spending to lure significant corporations to expand their operations in LAMEA. It is anticipated to stimulate the expansion of the market during the forecast horizon.
sales@straitsresearch.com